SELVAS Healthcare, Inc. (KOSDAQ: 208370)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,940.00
+890.00 (21.98%)
Sep 11, 2024, 11:11 AM KST
-51.52%
Market Cap 135.27B
Revenue (ttm) 28.56B
Net Income (ttm) 3.70B
Shares Out 25.72M
EPS (ttm) 143.92
PE Ratio 36.55
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,806,338
Open 4,025.00
Previous Close 4,050.00
Day's Range 4,025.00 - 5,110.00
52-Week Range 3,735.00 - 13,090.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 12, 2024

About SELVAS Healthcare

SELVAS Healthcare, Inc. manufactures and sells medical diagnostic devices and visual aids products. The company develops, manufactures, and sells body composition analyzers and automatic blood pressure monitors. It provides rehabilitation medical auxiliary equipment under HIMS brand name, as well as provides health solution under ACCUNIQ brand name. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1999 and is headquartered in Daeje... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 114
Stock Exchange KOSDAQ
Ticker Symbol 208370
Full Company Profile

Financial Performance

In 2023, SELVAS Healthcare's revenue was 29.81 billion, an increase of 7.68% compared to the previous year's 27.69 billion. Earnings were 5.17 billion, an increase of 83.79%.

Financial Statements

News

There is no news available yet.